STOCK TITAN

NVST Form 4: Acurio withholds 5,422 shares to cover RSU taxes

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Envista Holdings Corp (NVST) reporting person Veronica Acurio, identified as President, Orthodontics and an officer/director, had 5,422 shares of common stock withheld to satisfy tax-withholding on vested restricted stock units. The transaction is reported as a disposition at an effective price of $21.12 per share on 08/25/2025, leaving 50,323 shares beneficially owned following the withholding.

This Form 4 describes a routine tax-related withholding tied to equity compensation rather than an open-market sale; no options, derivatives or other transactions are reported.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Acurio's sale reflects routine tax withholding on vested RSUs, not an active disposition for liquidity; remaining ownership stays material.

The reported disposition of 5,422 shares at $21.12 per share was executed to satisfy tax obligations on vested restricted stock units, a common administrative action that reduces outstanding shares held by the executive but does not necessarily indicate a change in conviction. Post-transaction beneficial ownership of 50,323 shares preserves continued alignment with shareholders. No derivative activity or additional sales were disclosed, limiting immediate market-significance.

TL;DR: This filing documents a standard equity-compensation withholding event by a named executive officer; governance impact is minimal.

Withholding shares to cover tax on vested RSUs is routine and typically governed by company plans and policies. The report identifies the reporting person as both an officer and director, which maintains required disclosure transparency. Because the transaction is labeled as tax withholding and not as a discretionary sale, it is unlikely to raise governance concerns or trigger disclosure of any change in executive role or strategy.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Acurio Veronica

(Last) (First) (Middle)
C/O ENVISTA HOLDINGS CORPORATION
200 S. KRAEMER BLVD., BLDG. E

(Street)
BREA CA 92821

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Envista Holdings Corp [ NVST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Orthodontics
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 F 5,422(1) D $21.12 50,323 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Remarks:
/s/ Heather Turner, By POA from Veronica Acurio 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Envista Holdings Corp

NYSE:NVST

NVST Rankings

NVST Latest News

NVST Latest SEC Filings

NVST Stock Data

3.96B
162.99M
0.54%
119.49%
5.83%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
BREA